Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer

BACKGROUND: Tumors can influence peripheral immune macroenvironment, thereby creating opportunities for non-invasive serum/plasma immunobiomarkers for immunostratification and immunotherapy designing. However, current approaches for immunobiomarkers’ detection are largely quantitative, which is unre...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprooten, Jenny, Vankerckhoven, Ann, Vanmeerbeek, Isaure, Borras, Daniel M, Berckmans, Yani, Wouters, Roxanne, Laureano, Raquel S, Baert, Thais, Boon, Louis, Landolfo, Chiara, Testa, Antonia Carla, Fischerova, Daniela, Van Holsbeke, Caroline, Bourne, Tom, Chiappa, Valentina, Froyman, Wouter, Schols, Dominique, Agostinis, Patrizia, Timmerman, Dirk, Tejpar, Sabine, Vergote, Ignace, Coosemans, An, Garg, Abhishek D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603275/
https://www.ncbi.nlm.nih.gov/pubmed/34795003
http://dx.doi.org/10.1136/jitc-2021-003609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603275/
https://www.ncbi.nlm.nih.gov/pubmed/34795003
http://dx.doi.org/10.1136/jitc-2021-003609

Ejemplares similares